These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37542123)

  • 1. Antibiotic-induced collateral damage to the microbiota and associated infections.
    de Nies L; Kobras CM; Stracy M
    Nat Rev Microbiol; 2023 Dec; 21(12):789-804. PubMed ID: 37542123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.
    Kim S; Covington A; Pamer EG
    Immunol Rev; 2017 Sep; 279(1):90-105. PubMed ID: 28856737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the target pathogen: ecological effects of the hospital formulary.
    Goldstein EJ
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S21-31. PubMed ID: 21200181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.
    Pamer EG
    Science; 2016 Apr; 352(6285):535-8. PubMed ID: 27126035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rise of the guardians: Gut microbial maneuvers in bacterial infections.
    Gupta U; Dey P
    Life Sci; 2023 Oct; 330():121993. PubMed ID: 37536616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
    Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation.
    Langdon A; Crook N; Dantas G
    Genome Med; 2016 Apr; 8(1):39. PubMed ID: 27074706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial approaches for targeting antibiotic-resistant bacteria.
    Wong WF; Santiago M
    Microb Biotechnol; 2017 Sep; 10(5):1047-1053. PubMed ID: 28771951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At least it won't hurt: the personal risks of antibiotic exposure.
    Stewardson AJ; Huttner B; Harbarth S
    Curr Opin Pharmacol; 2011 Oct; 11(5):446-52. PubMed ID: 21775205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to improve antibiotic prescribing practices for hospital inpatients.
    Davey P; Brown E; Charani E; Fenelon L; Gould IM; Holmes A; Ramsay CR; Wiffen PJ; Wilcox M
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003543. PubMed ID: 23633313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antibiotics on human microbiota and subsequent disease.
    Keeney KM; Yurist-Doutsch S; Arrieta MC; Finlay BB
    Annu Rev Microbiol; 2014; 68():217-35. PubMed ID: 24995874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.
    Stracy M; Snitser O; Yelin I; Amer Y; Parizade M; Katz R; Rimler G; Wolf T; Herzel E; Koren G; Kuint J; Foxman B; Chodick G; Shalev V; Kishony R
    Science; 2022 Feb; 375(6583):889-894. PubMed ID: 35201862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of pathogens and pathobionts by the gut microbiota.
    Kamada N; Chen GY; Inohara N; Núñez G
    Nat Immunol; 2013 Jul; 14(7):685-90. PubMed ID: 23778796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rationale for the choice of an antibiotic for urinary tract infections with an emphasis on the environmental safety of therapy].
    Yakovlev SV; Suvorova MP
    Urologiia; 2021 Sep; (4):97-105. PubMed ID: 34486282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-mediated colonization resistance against intestinal pathogens.
    Buffie CG; Pamer EG
    Nat Rev Immunol; 2013 Nov; 13(11):790-801. PubMed ID: 24096337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underestimated collateral effects of antibiotic therapy in prosthesis-associated bacterial infections.
    Baldassarri L; Montanaro L; Creti R; Arciola CR
    Int J Artif Organs; 2007 Sep; 30(9):786-91. PubMed ID: 17918123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health.
    Ribeiro CFA; Silveira GGOS; Cândido ES; Cardoso MH; Espínola Carvalho CM; Franco OL
    ACS Infect Dis; 2020 Oct; 6(10):2544-2559. PubMed ID: 32786282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating eco-evolutionary biology into therapy to tackle antibiotic resistance.
    Sanz-García F; Gil-Gil T; Laborda P; Blanco P; Ochoa-Sánchez LE; Baquero F; Martínez JL; Hernando-Amado S
    Nat Rev Microbiol; 2023 Oct; 21(10):671-685. PubMed ID: 37208461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.